AML relapse after HSCT linked to potentially reversible immune changesNovember 2, 2018Leukemia, Myelodysplasia, Transplantation
The election’s impact on health care: Some bellwether races to watchNovember 2, 2018Practice Management
Novel risk factors for febrile neutropenia in NHL, solid tumorsNovember 2, 2018Patient & Survivor Care
Pricey precision medicine often financially toxic for cancer patientsNovember 1, 2018Practice Management
Genomic abnormalities shed light on racial disparity in myelomaNovember 1, 2018Lymphoma & Plasma Cell Disorders
Pembrolizumab extends survival of head and neck cancerNovember 1, 2018Head & Neck/Thyroid CancersImmuno-oncology
'Liver first' for select stage IV colon cancer gaining tractionNovember 1, 2018GastroenterologyGastrointestinal Cancer
Checkpoint inhibitor plus rituximab is active in non-Hodgkin lymphomaOctober 31, 2018Lymphoma & Plasma Cell DisordersFollicular Lymphoma
ATLAS: High-risk RCC patients might benefit from adjuvant axitinibOctober 31, 2018Renal Cell CarcinomaGenitourinary Cancer
